Seeking Alpha

Eli Lilly (LLY -1.1%), Amylin (AMLN -24.7%) and Alkermes (ALKS -14.9%) provide top-line results...

Eli Lilly (LLY -1.1%), Amylin (AMLN -24.7%) and Alkermes (ALKS -14.9%) provide top-line results from a head-to-head study, showing investigational diabetes therapy Bydureon didn't meet the pre-specified primary endpoint of non-inferiority to Victoza (NVO +5%). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs